Drug Type Small molecule drug |
Synonyms (S)-(−)-hesperidin, Cirantin, Ciratin + [3] |
Target- |
Action- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date- |
Regulation- |
Molecular FormulaC28H34O15 |
InChIKeyQUQPHWDTPGMPEX-QJBIFVCTSA-N |
CAS Registry520-26-3 |
Start Date31 Mar 2024 |
Sponsor / Collaborator |
Start Date18 Jul 2023 |
Sponsor / Collaborator |
Start Date02 Jun 2023 |
Sponsor / Collaborator |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D01038 | Hesperidin | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Coloboma of Optic Nerve | Discovery | China | 01 Jun 2023 |
Study | Phase | Population | Analyzed Enrollment | Group | Results | Evaluation | Publication Date |
---|
Phase 2 | Abdominal Pain | Dyspnea | Arthralgia | Confusion | Myalgia | Fever | Pharyngitis | Muscle Weakness | Chest Pain | COVID-19 | Cough | Nausea | Irritable Mood | Anosmia | Vomiting | Headache | 216 | (Hesperidin 1000mg) | iujafuhlox(yeonxbbbvu): Odds Ratio (OR) = 1.49 (95% CI, 0.60 - 3.69), P-Value = 0.3849 View more | - | 08 Apr 2022 | |
Placebo (Placebo 1000mg) |